Avricore Health (AVCRF) Current Deferred Revenue (2020 - 2022)

Avricore Health (AVCRF) has reported Current Deferred Revenue for 3 consecutive years, with -$185103.0 the latest figure, recorded in Q4 2023.

• In Q4 2023, Current Deferred Revenue fell 199.71% year-over-year to -$185103.0; the TTM figure through Dec 2023 stood at -$185103.0 (down 199.71% YoY), while the FY2023 annual figure was -$186773.9, down 196.36% from the prior year.
• Current Deferred Revenue slipped to -$185103.0 in Q4 2023 per AVCRF's latest filing, from $185649.1 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $185649.1 in Q4 2022 and bottomed at -$185103.0 in Q4 2023.
• Historically, Current Deferred Revenue has averaged $10583.7 across 3 years, with a median of $31205.1 in 2020.
• On a YoY basis, Current Deferred Revenue climbed as much as 199.71% in 2023 and fell as far as 199.71% in 2023.
• Avricore Health's Current Deferred Revenue stood at $31205.1 in 2020, then jumped by 494.93% to $185649.1 in 2022, then sank by 199.71% to -$185103.0 in 2023.
• Business Quant data shows AVCRF's Current Deferred Revenue at -$185103.0 in Q4 2023, $185649.1 in Q4 2022, and $31205.1 in Q2 2020.